Jessica McNeil1, Darren R Brenner1,2, Chelsea R Stone1, Rachel O'Reilly1, Yibing Ruan1, Jeff K Vallance3, Kerry S Courneya4, Kevin E Thorpe5,6, Doug J Klein7, Christine M Friedenreich1,2. 1. Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services, Calgary, Alberta, CANADA. 2. Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, CANADA. 3. Center for Nursing and Health Studies, Faculty of Health Disciplines, Athabasca University, Athabasca, Alberta, CANADA. 4. Faculty of Physical Education and Recreation, University of Alberta, Edmonton, Alberta, CANADA. 5. Dalla Lana School of Public Health, Faculty of Medicine, University of Toronto, Toronto, Ontario, CANADA. 6. Applied Health Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, CANADA. 7. Department of Family Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, CANADA.
Abstract
PURPOSE: To prescribe different physical activity (PA) intensities using activity trackers to increase PA, reduce sedentary time, and improve health outcomes among breast cancer survivors. The maintenance effect of the interventions on study outcomes was also assessed. METHODS: The Breast Cancer and Physical Activity Level pilot trial randomized 45 breast cancer survivors to a home-based, 12-wk lower (300 min·wk at 40%-59% of HR reserve) or higher-intensity PA (150 min·wk at 60%-80% of HR reserve), or no PA intervention/control. Both intervention groups received Polar A360® activity trackers. Study outcomes assessed at baseline, 12 and 24 wk included PA and sedentary time (ActiGraph GT3X+), health-related fitness (e.g., body composition, cardiopulmonary fitness/V˙O2max), and patient-reported outcomes (e.g., quality of life). Intention-to-treat analyses were conducted using linear mixed models and adjusted for baseline outcomes. RESULTS: Increases in moderate-vigorous intensity PA (least squares adjusted group difference [LSAGD], 0.6; 95% confidence interval [CI], 0.1-1.0) and decreases in sedentary time (LSAGD, -1.2; 95% CI, -2.2 to -0.2) were significantly greater in the lower-intensity PA group versus control at 12 wk. Increases in V˙O2max at 12 wk in both interventions groups were significantly greater than changes in the control group (lower-intensity PA group LSAGD, 4.2; 95% CI, 0.5-8.0 mL·kg·min; higher-intensity PA group LSAGD, 5.4; 95% CI, 1.7-9.1 mL·kg·min). Changes in PA and V˙O2max remained at 24 wk, but differences between the intervention and control groups were no longer statistically significant. CONCLUSIONS: Increases in PA time and cardiopulmonary fitness/V˙O2max can be achieved with both lower- and higher-intensity PA interventions in breast cancer survivors. Reductions in sedentary time were also noted in the lower-intensity PA group.
RCT Entities:
PURPOSE: To prescribe different physical activity (PA) intensities using activity trackers to increase PA, reduce sedentary time, and improve health outcomes among breast cancer survivors. The maintenance effect of the interventions on study outcomes was also assessed. METHODS: The Breast Cancer and Physical Activity Level pilot trial randomized 45 breast cancer survivors to a home-based, 12-wk lower (300 min·wk at 40%-59% of HR reserve) or higher-intensity PA (150 min·wk at 60%-80% of HR reserve), or no PA intervention/control. Both intervention groups received Polar A360® activity trackers. Study outcomes assessed at baseline, 12 and 24 wk included PA and sedentary time (ActiGraph GT3X+), health-related fitness (e.g., body composition, cardiopulmonary fitness/V˙O2max), and patient-reported outcomes (e.g., quality of life). Intention-to-treat analyses were conducted using linear mixed models and adjusted for baseline outcomes. RESULTS: Increases in moderate-vigorous intensity PA (least squares adjusted group difference [LSAGD], 0.6; 95% confidence interval [CI], 0.1-1.0) and decreases in sedentary time (LSAGD, -1.2; 95% CI, -2.2 to -0.2) were significantly greater in the lower-intensity PA group versus control at 12 wk. Increases in V˙O2max at 12 wk in both interventions groups were significantly greater than changes in the control group (lower-intensity PA group LSAGD, 4.2; 95% CI, 0.5-8.0 mL·kg·min; higher-intensity PA group LSAGD, 5.4; 95% CI, 1.7-9.1 mL·kg·min). Changes in PA and V˙O2max remained at 24 wk, but differences between the intervention and control groups were no longer statistically significant. CONCLUSIONS: Increases in PA time and cardiopulmonary fitness/V˙O2max can be achieved with both lower- and higher-intensity PA interventions in breast cancer survivors. Reductions in sedentary time were also noted in the lower-intensity PA group.
Authors: Renee L Kokts-Porietis; Chelsea R Stone; Christine M Friedenreich; Alyssa Froese; Meghan McDonough; Jessica McNeil Journal: Support Care Cancer Date: 2020-01-07 Impact factor: 3.603
Authors: Erik D Hanson; Mohamdod Alzer; Jackson Carver; Cameron K Stopforth; Alexander R Lucas; Young E Whang; Matthew I Milowsky; David B Bartlett; Michael R Harrison; Rhonda L Bitting; Allison M Deal; Lee Stoner; A C Hackney; Claudio L Battaglini Journal: Prostate Cancer Prostatic Dis Date: 2022-03-19 Impact factor: 5.554
Authors: Britni R Belcher; Dong-Woo Kang; Alexandra G Yunker; Christina M Dieli-Conwright Journal: Curr Oncol Rep Date: 2022-07-13 Impact factor: 5.945
Authors: Whitney A Welch; Payton Solk; Lisa Auster-Gussman; Kara L Gavin; Madelyn Whitaker; Erin Cullather; Emily Izenman; Kerry S Courneya; Ronald Ackermann; Bonnie Spring; David Cella; Frank Penedo; Siobhan M Phillips Journal: Transl Behav Med Date: 2022-02-16 Impact factor: 3.626
Authors: Jessica McNeil; Mina Fahim; Chelsea R Stone; Rachel O'Reilly; Kerry S Courneya; Christine M Friedenreich Journal: J Cancer Surviv Date: 2021-03-22 Impact factor: 4.442
Authors: Nathalie LeVasseur; Wei Cheng; Sasha Mazzarello; Mark Clemons; Lisa Vandermeer; Lee Jones; Anil Abraham Joy; Pauline Barbeau; Dianna Wolfe; Nadera Ahmadzai; Mona Hersi; Carol Stober; Risa Shorr; John Hilton; Brian Hutton Journal: PLoS One Date: 2021-02-04 Impact factor: 3.240
Authors: Famke Huizinga; Nico-Derk Lodewijk Westerink; Annette J Berendsen; Annemiek M E Walenkamp; Mathieu H G DE Greef; Juliët K Oude Nijeweeme; Geertruida H DE Bock; Marjolein Y Berger; Daan Brandenbarg Journal: Med Sci Sports Exerc Date: 2021-12-01 Impact factor: 5.411
Authors: Selina Khoo; Najihah Mohbin; Payam Ansari; Mahfoodha Al-Kitani; Andre Matthias Müller Journal: Int J Environ Res Public Health Date: 2021-05-28 Impact factor: 3.390